Home
>
US Stocks
>
Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc
AUPH

Aurinia Pharmaceuticals Inc (AUPH)

$24.4436.31%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
21.82
Today Low/High
21.68 / 24.44
52 Week Low/High
$9.72 / $20.5
Market Cap
$1.67B

Company Details

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.
Organisation
Aurinia Pharmaceuticals Inc
Headquaters
Victoria, British Columbia, Canada
Employees
294
Industry
Health Technology
CEO
Peter Greenleaf

Discover more

Frequently Asked Questions

What is Aurinia Pharmaceuticals Inc (AUPH) share price today?

Can Indians buy Aurinia Pharmaceuticals Inc (AUPH) shares?

How can I buy Aurinia Pharmaceuticals Inc (AUPH) shares from India?

Can Fractional shares of Aurinia Pharmaceuticals Inc (AUPH) be purchased?

What are the documents required to start investing in Aurinia Pharmaceuticals Inc (AUPH) stocks?

We are a SEBI registered investement advisor